Precision BioSciences, Inc.
DTIL
$7.43
$0.131.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.73M | -43.60M | -45.72M | -83.60M | -78.26M |
| Total Depreciation and Amortization | 2.60M | 2.69M | 2.75M | 2.83M | 3.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.79M | 15.99M | 6.37M | 8.62M | 4.28M |
| Change in Net Operating Assets | -28.55M | -33.81M | -29.24M | -1.13M | 6.88M |
| Cash from Operations | -51.90M | -58.73M | -65.84M | -73.28M | -63.92M |
| Capital Expenditure | -37.00K | -39.00K | -85.00K | -163.00K | -202.00K |
| Sale of Property, Plant, and Equipment | 66.00K | 70.00K | 66.00K | 22.00K | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -450.00K | -465.00K | -615.00K | -265.00K | -290.00K |
| Cash from Investing | -421.00K | -434.00K | -634.00K | -406.00K | -487.00K |
| Total Debt Issued | -- | -- | -- | -20.00K | 22.47M |
| Total Debt Repaid | -- | -- | -- | 0.00 | -22.51M |
| Issuance of Common Stock | 79.92M | 85.22M | 95.16M | 23.59M | 25.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 79.92M | 85.22M | 95.16M | 23.57M | 25.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.60M | 26.06M | 28.69M | -50.12M | -38.77M |